The Oncology Institute, Inc. TOI Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s preferred stock, par or stated value per share?
- The Oncology Institute, Inc. (TOI) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has The Oncology Institute, Inc.'s preferred stock, par or stated value per share changed year-over-year?
- The Oncology Institute, Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for The Oncology Institute, Inc.'s preferred stock, par or stated value per share?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.